RIVA-PYRANTEL PAMOATE
Identification of Riva-Pyrantel Pamoate
| No description |
Google image searchProduct monograph
Active ingredient
pyrantel (pyrantel pamoate), 125 MG
DIN: 02535467
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: OTC
Company: LABORATOIRE RIVA INC.
Date: 17-FEB-2025
ATC:
- P02 — ANTHELMINTICS (ATC, ATC/DDD, )
- P02C — ANTINEMATODAL AGENTS (ATC, ATC/DDD)
- P02CC — Tetrahydropyrimidine derivatives (ATC, ATC/DDD)
- P02CC01 — PYRANTEL (ATC/DDD)
Reference brand drug: Combantrin
